The global transitional care management services market was estimated at USD 175.71 billion in 2021 and it is expected to surpass around USD 729.8 billion by 2030, poised to grow at a CAGR of 17.14% from 2022 to 2030.
Report Highlights
The growing geriatric population, rising number of diseases, injuries, and surgeries, and demand for the post-discharge facility are anticipated to contribute to healthy growth in the market. Besides, cost-effectiveness has fueled market growth. For instance, according to the rural health information hub, the U.S. is one of the major countries with a geriatric population. The country’s more than 46 million older adults (aged 65 and above) are living in the U.S. Between 2020 and 2030, the number of older people is expected to increase by almost 18 million. Besides, by 2050, the number is probable to grow to almost 90 million. This factor is expected to drive the market at a rapid pace.
The COVID-19 pandemic affected transitional care management (TCM) services in the initial phase of the pandemic as most of the population was not able to access the services due to lockdown and safety concerns. However, TCM services were offered with the help of non-face to-face (telehealth), thereby increasing the demand for telemedicine. Post-COVID-19, the market has witnessed rising demand for transitional care services, specifically from the elderly population.
Furthermore, a rising number of market players and increasing demand to improve patient care have led to the adoption of transitional care management services. PharMerica mentioned that home-based primary care has resulted in a 20% reduction in emergency room visits and a 50% reduction in hospital readmissions. Hence, TCM services are foreseen to reduce post-discharge complications and are expected to drive the demand for patient transitional care.
Scope of The Report
Report Coverage | Details |
Market Size in 2021 | USD 175.71 billion |
Revenue Forecast by 2030 | USD 729.8 billion |
Growth rate from 2022 to 2030 | CAGR of 17.14% |
Base Year | 2021 |
Forecast Period | 2022 to 2030 |
Segmentation | Service, end-use, region |
Companies Covered |
Humworld Inc.; Rijuven Corp.; PharMerica Corporation; CareVitality; ACT Health Solutions; Medsien; Wellsky; Nextgen Healthcare; Prohealth Select; Well Living Initiative (WLI) |
Service Insights
In 2021, the patient TCM services segment dominated the market with a share of over 30.02% owing to the reduced costs in the months after the services are provided. For instance, PharMerica mentioned that home-based primary care has led to a 20% reduction in emergency room visits and a 50% reduction in hospital readmissions. Hence, TCM services are foreseen to reduce post-discharge complications and these are expected to drive the demand for patient TCM services over the forecast period.
The billing TCM services are anticipated to register the fastest CAGR of 18.27% from 2022 to 2030. The billing of TCM services is highly concentrated among healthcare TCM service providers. These TCM services focus on reviewing the patient’s discharge procedure and payment information, which includes the potential requirement for tests, treatment, and treatment follow-ups as needed.
End-use Insights
In 2021, the community settings segment accounted for the largest share of over 55.11%. Community settings include home, domiciliary, rest home, and assisted living. The community settings involve half of the post-discharge care interventions. These facilities offer an opportunity to improve patient care and quality of life while reducing the overall costs of hospital stay and reducing the chances of re-hospitalization.
Community centers are considered a convenient option for patient recovery from life-threatening traumas, especially in the case of geriatric patients as they lower the risk of hospital readmission, reduce the complications related to the transfer of care, and improve overall patient satisfaction, thereby driving the segment.
Regional Insights
In 2021, North America dominated the market with a share of over 45.07%. The market in North America is highly competitive due to the key market players operating in this region. The growing burden of the geriatric population and the presence of well-developed healthcare facilities have created new growth opportunities for the TCM services market. In addition, the growing number of surgeries, injuries, and serious illnesses has contributed to the demand for after-care.
Asia Pacific is expected to expand at the fastest CAGR of 18.2% during the forecast period owing to the growing elderly population, rising number of surgeries, the burden of diseases, and the development of healthcare facilities in the region. The presence of developing countries such as China and India has led the market to new growth avenues in the future. For instance, in October 2021, HCAH (formerly Healthcare atHOME) launched a third transition care center in India. It is the first in North India. The transition care center by HCAH is likely to fill the healthcare gap between homes and tertiary care hospitals.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Transitional Care Management Services Market
5.1. COVID-19 Landscape: Transitional Care Management Services Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Transitional Care Management Services Market, By Service
8.1. Transitional Care Management Services Market, by Service, 2022-2030
8.1.1. Patient TCM Services
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Healthcare TCM Services
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Billing TCM Services
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Documenting TCM Services
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Transitional Care Management Services Market, By End-use
9.1. Transitional Care Management Services Market, by End-use, 2022-2030
9.1.1. Inpatient Settings
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Community Settings
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Transitional Care Management Services Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Service (2017-2030)
10.1.2. Market Revenue and Forecast, by End-use (2017-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Service (2017-2030)
10.1.3.2. Market Revenue and Forecast, by End-use (2017-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Service (2017-2030)
10.1.4.2. Market Revenue and Forecast, by End-use (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Service (2017-2030)
10.2.2. Market Revenue and Forecast, by End-use (2017-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Service (2017-2030)
10.2.3.2. Market Revenue and Forecast, by End-use (2017-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Service (2017-2030)
10.2.4.2. Market Revenue and Forecast, by End-use (2017-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Service (2017-2030)
10.2.5.2. Market Revenue and Forecast, by End-use (2017-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Service (2017-2030)
10.2.6.2. Market Revenue and Forecast, by End-use (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Service (2017-2030)
10.3.2. Market Revenue and Forecast, by End-use (2017-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Service (2017-2030)
10.3.3.2. Market Revenue and Forecast, by End-use (2017-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Service (2017-2030)
10.3.4.2. Market Revenue and Forecast, by End-use (2017-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Service (2017-2030)
10.3.5.2. Market Revenue and Forecast, by End-use (2017-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Service (2017-2030)
10.3.6.2. Market Revenue and Forecast, by End-use (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Service (2017-2030)
10.4.2. Market Revenue and Forecast, by End-use (2017-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Service (2017-2030)
10.4.3.2. Market Revenue and Forecast, by End-use (2017-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Service (2017-2030)
10.4.4.2. Market Revenue and Forecast, by End-use (2017-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Service (2017-2030)
10.4.5.2. Market Revenue and Forecast, by End-use (2017-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Service (2017-2030)
10.4.6.2. Market Revenue and Forecast, by End-use (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Service (2017-2030)
10.5.2. Market Revenue and Forecast, by End-use (2017-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Service (2017-2030)
10.5.3.2. Market Revenue and Forecast, by End-use (2017-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Service (2017-2030)
10.5.4.2. Market Revenue and Forecast, by End-use (2017-2030)
Chapter 11. Company Profiles
11.1. Humworld Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Rijuven Corp.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. PharMerica Corporation
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. CareVitality
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. LTE Scientific
11.5. ACT Health Solutions
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Medsien
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Wellsky
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Nextgen Healthcare
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Prohealth Select
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Well Living Initiative (WLI)
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms